Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
2. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2h-pyran-3,4,5-triol
3. Bms 512148
4. Bms-512148
5. Bms512148
6. Dapagliflozin
7. Farxiga
8. Forxiga
1. 960404-48-2
2. Dapagliflozin Propanediol Monohydrate
3. Dapagliflozin Propanediol Hydrate
4. Farxiga
5. Dapagliflozin ((2s)-1,2-propanediol, Hydrate)
6. Bms-512148-05
7. Dapagliflozin S-propylene Glycol Monohydrate
8. Dapagliflozin Propylene Glycolate Hydrate
9. Chebi:85079
10. Dapagliflozin Propanediol [usan]
11. Dapagliflozin Mixture With Propylene Glycol, Hydrate
12. 887k2391vh
13. (2s,3r,4r,5s,6r)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;(2s)-propane-1,2-diol;hydrate
14. Dapagliflozin [usan:inn]
15. Dapagliflozin Propylene Glycol Hydrate
16. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol Compound With (s)-propane-1,2-diol (1:1) Hydrate
17. D-glucitol, 1,5-anhydro-1-c-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1s)-, Compd. With (2s)-1,2-propanediol, Hydrate (1:1:1)
18. Unii-887k2391vh
19. Dapagliflozin Propylene Glycolate Hydrate [jan]
20. Dapagliflozin (s)-propylene Glycol Hydrate
21. Chembl2103802
22. Dtxsid00914678
23. Ex-a2824
24. Dapagliflozin Propylene Glycol
25. Hy-10450a
26. Mfcd28167768
27. S5566
28. Akos027250601
29. Ccg-269711
30. Ac-29230
31. As-64915
32. Dapagliflozin (2s)-1,2-propanediol Hydrate
33. F20667
34. Bms-512148 (2s)-1,2-propanediol, Hydrate
35. Dapagliflozin (2s)-1,2-propanediol Monohydrate
36. Xigduo Component Dapagliflozin Propanediol
37. A900162
38. Dapagliflozin Propanediol Component Of Xigduo
39. Dapagliflozin Propanediol Monohydrate [who-dd]
40. Q27158320
41. Dapagliflozin Propanediol Monohydrate [ema Epar]
42. Dapagliflozin Compound With (2s)-1,2-propanediol Hydrate
43. Dapagliflozin Compound With (2s)-1,2-propanediol Hydrate [mi]
44. (2s)-propane-1,2-diol (2s,3r,4r,5s,6r)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol Hydrate
45. (2s)-propane-1,2-diol--(1s)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-d-glucitol--water (1/1/1)
46. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro- 2h-pyran-3,4,5-triol, (2s)-propane-1,2-diol (1:1) Monohydrate
47. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol (s)-propane-1,2-diol Hydrate
48. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol, (2s)-propane-1,2-diol (1:1) Monohydrate
49. 1700615-13-9
| Molecular Weight | 503.0 g/mol |
|---|---|
| Molecular Formula | C24H35ClO9 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 502.1969604 g/mol |
| Monoisotopic Mass | 502.1969604 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 493 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Forxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance.
- in addition to other medicinal products for the treatment of type 2 diabetes.
For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied.
Heart failure
- Forxiga is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction.
Chronic kidney disease
- Forxiga is indicated in adults for the treatment of chronic kidney disease.
Type 2 diabetes mellitus
Edistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance.
- in addition to other medicinal products for the treatment of type 2 diabetes.
For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 and 5. 1.
Heart failure
Edistride is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction.
Chronic kidney disease
Edistride is indicated in adults for the treatment of chronic kidney disease.
Sodium-Glucose Transporter 2 Inhibitors
Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)
A10BK01
A10BK01
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33026
Submission : 2018-08-14
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm :
NDC Package Code : 71796-030
Start Marketing Date : 2019-08-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Poonglim Pharmaceutical Co., Ltd.
Registration Date : 2022-11-24
Registration Number : Su574-16-ND(1)
Manufacturer Name : Dr. Reddy's Laboratories Limited
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No's. 28 to 34, 36 to 37, 40, 50 to 53 & 03 Survey No' s. 57 to 58, 60, 72 to 73, 76 to 77 & 80 Devunipalavalasa Village, Ranastalam Mandal, Srikakulam District-532 409, Andhra Pradesh, India
| Available Reg Filing : ASMF, CDMF |
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36048
Submission : 2021-06-28
Status : Active
Type : II
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm :
NDC Package Code : 42765-037
Start Marketing Date : 2021-06-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Seongwoo Chemical Co., Ltd.
Registration Date : 2025-05-19
Registration Number : Su473-32-ND
Manufacturer Name : Metrochem API Pvt Ltd, Unit- IV
Manufacturer Address : Plot No. 34B, 40B & 60B, JN Pharma City, Thanam (V) Parawada (M), Anakapalli District – 531 021, Andhra Pradesh, India.
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39760
Submission : 2024-04-29
Status : Active
Type : II
Date of Issue : 2025-06-16
Valid Till : 2028-06-16
Written Confirmation Number : WC-0036
Address of the Firm :
| Available Reg Filing : ASMF |
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34235
Submission : 2019-10-15
Status : Active
Type : II
Date of Issue : 2025-09-18
Valid Till : 2028-07-02
Written Confirmation Number : WC-0195
Address of the Firm :
NDC Package Code : 76072-1014
Start Marketing Date : 2019-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-10-13
Registration Number : Su434-24-ND
Manufacturer Name : Cohance Lifesciences Limited, API Unit-III
Manufacturer Address : Plot No. - 3102/B, GIDC, City – Ankleshwar - 393 002, Dist. - Bharuch, Gujarat State, India.
| Available Reg Filing : ASMF, CN, BR |
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38010
Submission : 2023-02-23
Status : Active
Type : II
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2024-10-28
Registration Number : Su434-68-ND
Manufacturer Name : Ami Lifesciences Pvt. Ltd.
Manufacturer Address : Block No. 82/B, ECP Road, At & Post. Karakhadi-391 450, Taluka:Padra, Dist.Vadodara, Gujarat, India
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
GDUFA
DMF Review : Complete
Rev. Date : 2019-07-16
Pay. Date : 2018-12-20
DMF Number : 33387
Submission : 2018-12-30
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33026
Submission : 2018-08-14
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36048
Submission : 2021-06-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39760
Submission : 2024-04-29
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34235
Submission : 2019-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38010
Submission : 2023-02-23
Status : Active
Type : II
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-21
Pay. Date : 2018-10-30
DMF Number : 32972
Submission : 2018-11-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27838
Submission : 2015-06-27
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32571
Submission : 2018-04-30
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2017-06-07
Pay. Date : 2017-05-11
DMF Number : 28086
Submission : 2014-03-25
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Dapagliflozin Propanediol Monohydrate
About the Company : Over 75 years of experience in process development and cGMP manufacturing make Polpharma API a key division of a leading Polish pharmaceutical group. Operating from our FDA-approve...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Dapagliflozin Propanediol Monohydrate
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Dapagliflozin Propanediol Monohydrate
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates, CDMO/CRO/OEM, and Technology Transfer of Finished Formulat...
About the Company : Established in 1984, Neuland Laboratories Limited is a publicly listed company headquartered in Hyderabad, India. The company provides solutions across the entire spectrum of the p...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Dapagliflozin Propanediol Monohydrate
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About the Company : Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its produc...
Dapagliflozin Propanediol Monohydrate
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
Dapagliflozin Propanediol Monohydrate
About the Company : Chynops Pharma, a company certified with ISO 9001:2015, is situated in Ahmedabad, India. We specialize in exporting, supplying, and trading a wide range of products, including APIs...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
42
PharmaCompass offers a list of Dapagliflozin Propanediol Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dapagliflozin Propanediol Monohydrate manufacturer or Dapagliflozin Propanediol Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dapagliflozin Propanediol Monohydrate manufacturer or Dapagliflozin Propanediol Monohydrate supplier.
PharmaCompass also assists you with knowing the Dapagliflozin Propanediol Monohydrate API Price utilized in the formulation of products. Dapagliflozin Propanediol Monohydrate API Price is not always fixed or binding as the Dapagliflozin Propanediol Monohydrate Price is obtained through a variety of data sources. The Dapagliflozin Propanediol Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BMS-512148-05 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BMS-512148-05, including repackagers and relabelers. The FDA regulates BMS-512148-05 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BMS-512148-05 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BMS-512148-05 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BMS-512148-05 supplier is an individual or a company that provides BMS-512148-05 active pharmaceutical ingredient (API) or BMS-512148-05 finished formulations upon request. The BMS-512148-05 suppliers may include BMS-512148-05 API manufacturers, exporters, distributors and traders.
click here to find a list of BMS-512148-05 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A BMS-512148-05 DMF (Drug Master File) is a document detailing the whole manufacturing process of BMS-512148-05 active pharmaceutical ingredient (API) in detail. Different forms of BMS-512148-05 DMFs exist exist since differing nations have different regulations, such as BMS-512148-05 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A BMS-512148-05 DMF submitted to regulatory agencies in the US is known as a USDMF. BMS-512148-05 USDMF includes data on BMS-512148-05's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The BMS-512148-05 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of BMS-512148-05 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a BMS-512148-05 Drug Master File in Korea (BMS-512148-05 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of BMS-512148-05. The MFDS reviews the BMS-512148-05 KDMF as part of the drug registration process and uses the information provided in the BMS-512148-05 KDMF to evaluate the safety and efficacy of the drug.
After submitting a BMS-512148-05 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their BMS-512148-05 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of BMS-512148-05 suppliers with KDMF on PharmaCompass.
A BMS-512148-05 written confirmation (BMS-512148-05 WC) is an official document issued by a regulatory agency to a BMS-512148-05 manufacturer, verifying that the manufacturing facility of a BMS-512148-05 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting BMS-512148-05 APIs or BMS-512148-05 finished pharmaceutical products to another nation, regulatory agencies frequently require a BMS-512148-05 WC (written confirmation) as part of the regulatory process.
click here to find a list of BMS-512148-05 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing BMS-512148-05 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for BMS-512148-05 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture BMS-512148-05 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain BMS-512148-05 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a BMS-512148-05 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of BMS-512148-05 suppliers with NDC on PharmaCompass.
BMS-512148-05 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BMS-512148-05 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BMS-512148-05 GMP manufacturer or BMS-512148-05 GMP API supplier for your needs.
A BMS-512148-05 CoA (Certificate of Analysis) is a formal document that attests to BMS-512148-05's compliance with BMS-512148-05 specifications and serves as a tool for batch-level quality control.
BMS-512148-05 CoA mostly includes findings from lab analyses of a specific batch. For each BMS-512148-05 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BMS-512148-05 may be tested according to a variety of international standards, such as European Pharmacopoeia (BMS-512148-05 EP), BMS-512148-05 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BMS-512148-05 USP).